Variable bioavailability following repeated oral doses of etoposide
- 1 November 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (11), 1315-1319
- https://doi.org/10.1016/0277-5379(85)90310-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- STRIPE: An interactive computer program for the analysis of drug pharmacokineticsJournal of Pharmacological Methods, 1983
- Small cell carcinoma of the lungCancer Treatment Reviews, 1982
- A review of etoposide in patients with non-small-cell lung cancer (NSCLC)Cancer Treatment Reviews, 1982
- Etoposide as single agent and in combination chemotherapy of bronchogenic carcinomaCancer Treatment Reviews, 1982
- Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhoodCancer Treatment Reviews, 1982
- Etoposide salvage therapy for refractory germ cell tumors: an updateCancer Treatment Reviews, 1982
- Etoposide as single agent and in combination with cis-platinum for malignant lymphomasCancer Treatment Reviews, 1982
- Etoposide (VP-16-213)Cancer Treatment Reviews, 1979
- Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivativesEuropean Journal of Cancer (1965), 1975
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948